BACKGROUND: Human follicular¯uid contains several substances, such as cytokines and growth factors, which may affect follicular growth and maturation. The present study examines the relative contribution of macrophages and granulosa cells in the production of vascular endothelial growth factor (VEGF) and adrenomedullin in the human ovulatory follicle. METHODS: Both follicular¯uid samples and blood samples were obtained at the time of oocyte retrieval following ovarian stimulation from 20 women undergoing IVF treatment because of male infertility. Human follicular¯uid macrophages and luteinized granulosa cells were obtained from pooled follicular¯uid of individual patients. Accumulation of VEGF and adrenomedullin in the culture medium of the isolated macrophages and human granulosa cells was determined at variable time intervals ranging from 0 to 48 h. Plasma and follicular uid concentrations of VEGF and adrenomedullin were also measured. RESULTS: The follicular¯uid concentrations of VEGF and adrenomedullin were signi®cantly higher than those found in plasma. After 48 h, accumulation of VEGF in the culture medium of follicular¯uid macrophages was signi®cantly higher than that released in the culture medium of luteinized granulosa cells. In contrast, the production rate of adrenomedullin by follicular¯uid macrophages was similar to that found in granulosa cells. VEGF secreted by follicular¯uid macrophages increased progressively within 48 h of cell culture. A similar response pattern was observed with the culture medium of luteinized granulosa cells, but with lower production rates. CONCLUSIONS: This study suggests for the ®rst time that both luteinized granulosa cells and macrophages actively secrete VEGF and adrenomedullin into follicular uid in the human ovary.
Introduction
The pre-ovulatory follicle provides a unique physiological example of rapid growth associated with signi®cant changes in follicular vascularity including greater microvascular perfusion (Tanaka et al., 1989; Zackrisson et al., 2000) , increased capillary density (Cavender and Murdoch, 1988) and enhanced capillary permeability (Okuda et al., 1983; Neeman et al., 1997) . These processes are enhanced in IVF cycles where ovarian stimulation with exogenous gonadotrophins is used in order to induce multiple follicular growth and maturation.
Human follicular¯uid contains several substances, such as cytokines and growth factors, which may affect follicular growth and maturation, ovulation and follicular atresia (Bra Ènnstro Èm and Norman, 1993) . Vascular endothelial growth factor (VEGF) is an endothelial-speci®c mitogenic and permeability agent which is considered to be a key factor associated with rapid vascular growth in a variety of physiological and pathological conditions (Ferrara and Davis-Smyth, 1997; Lebovic et al., 1999) . VEGF is expressed and secreted in the normal premenopausal human ovary in a cyclic manner and regulated by gonadotrophin secretion during the menstrual cycle. VEGF has a paracrine and/or autocrine function necessary for normal ovarian function, mediating angiogenesis and vascular permeability. VEGF has also been implicated in the regulation of angiogenesis in the endometrium (Smith, 2001 ) and placenta (Ong et al., 2000) , and embryonic development (Breier, 2000) . Thus, this agent is critical for normal reproductive function (Geva and Jaffe, 2000) . We and others have reported that follicular¯uid from IVF patients contains signi®cant concentrations of VEGF (Lee et al., 1997a; Friedman et al., 1998; Manau et al., 2000) . VEGF mRNA expression has been detected within the dominant follicle and the corpus luteum of primate species, and both FSH and LH directly stimulate VEGF synthesis by non-human primate granulosa cells (Christenson and Stouffer, 1997; Lebovic et al., 1999) .
In addition, we ®rst reported that there was a signi®cantly higher amount of adrenomedullin present in follicular¯uid relative to plasma (Manau et al., 2000) . Adrenomedullin is a potent, long-lasting, multifunctional peptide ®rst isolated from human pheochromocytoma. Subsequent studies have shown that adrenomedullin is expressed in a variety of tissues and has diverse physiological actions (Hinson et al., 2000) . Adrenomedullin has been shown to be present throughout the female reproductive system and, in light of its known roles, it has been suggested that adrenomedullin may have important regulatory roles in reproductive tissues (Hinson et al., 2000) . Recently, adrenomedullin and its receptor have been found in the human granulosa cells at the pre-ovulatory stage and at the midluteal phase (Moriyama et al., 2000) . Adrenomedullin released by the ovary may act as a paracrine/autocrine hormone in regulating follicle growth or maturation, or may be implicated in the luteinization of ovarian follicles (Abe et al., 2000; Moriyama et al., 2000) . It is also possible that adrenomedullin derived from the ovary may have a role in the secretion of gonadotrophins in the pituitary gland (Montuenga et al., 2000) . Adrenomedullin is also an autocrine growth factor for human endometrial endothelial cells and is involved in endometrial angiogenesis Nikitenko et al., 2000) . During pregnancy, adrenomedullin may be involved in the maternal haemodynamic adaptations to gestation, may play a role during human labour and may be implicated in fetal growth and development (Garayoa et al., 2002; Yamashiro et al., 2002; Al-Ghafra et al., 2003) .
Although granulosa luteal cells predominate in follicular uid, macrophages have been suggested to play important roles in ovarian function and are a source of growth factors and secretory products in the ovary at various stages of follicular development (Bra Ènnstro Èm and Norman, 1993) . The numbers of macrophages are elevated in the periovulatory period and they constitute up to 15% of cells identi®ed in the follicular¯uid at the time of oocyte retrieval in IVF patients (Loukides et al., 1990) . Remarkably, recent studies have revealed that monocyte-derived macrophages secrete both VEGF (Ono et al., 1999; Barbera-Guillem et al., 2002) and adrenomedullin (Nakayama et al., 1999; Elsasser and Kahl, 2002) .
Therefore, the present study examines the relative contribution of macrophages and granulosa cells in the production of VEGF and adrenomedullin in the human ovulatory follicle.
Materials and methodS

Patients, stimulation protocol and retrieval
Both follicular¯uid samples and blood samples were obtained at the time of oocyte retrieval following ovarian stimulation from 20 consecutive women ful®lling the following inclusion criteria. They were aged <38 years (range 29±37; mean, 34 years) and underwent IVF treatment because of male infertility. All patients had both ovaries and regular menstrual cycles with normal ovulatory function as shown by cycle day 3 FSH concentration <10 IU/l, and midluteal serum progesterone and prolactin determinations, timed premenstrual biopsy and ultrasonographic scanning indicative of ovulatory cycles. All of them had normal blood pressure and body mass index (mean 24.7 kg/m 2 , range 18.7±28.5 kg/m 2 ), were non-smoking and were not taking any medication or involved in intensive exercise. All patients had multiple follicular development and successful oocyte retrieval, the mean (TSEM) peak serum estradiol concentration being 2354.15 T 138.73 pg/ml and the mean number of oocytes obtained being 11.75 T 0.77. Seven women became pregnant, and no patient developed ovarian hyperstimulation syndrome. The sample size of 20 patients was decided arbitrarily but in keeping with previous studies on the subject (Loukides et al., 1990; Lee et al., 1997b; Doldi et al., 1999; Garrido et al., 2001; Agrawal et al., 2002) .
Controlled ovarian stimulation for IVF was performed according to a protocol previously reported, including gonadotrophin ovarian stimulation under pituitary suppression with a GnRH agonist (Balasch et al., 2001) . Brie¯y, daily s.c. leuprolide acetate was started in the midluteal phase of the previous cycle, and gonadotrophin stimulation of the ovaries was started 13±14 days later when the serum estradiol concentration declined to <50 pg/ml and a vaginal ultrasonographic scan showed an absence of follicles >10 mm diameter. On days 1 and 2 of ovarian stimulation, six and four ampoules/ day of recombinant FSH (Gonal-F, Serono S.A., Madrid, Spain), respectively, were administered s.c. On days 3, 4 and 5 of ovarian stimulation, two ampoules/day of FSH were administered to each patient. From day 6 onwards, FSH was administered on an individual basis according to the ovarian response.
Sequential transvaginal ultrasonography and serum estradiol measurements were carried out to assess follicular development. Ultrasonic scans were performed with a 5 mHz vaginal transducer attached to an Aloka sector scanner (model SSD-620, Aloka, Tokyo, Japan). Finally, HCG (5000 IU) (Profasi; Serono S.A.) was administered i.m. when a consistent rise in serum estradiol concentration was associated with the presence of two or more follicles of b18 mm diameter. Oocyte aspiration was performed by vaginal ultrasonography 35±36 h after HCG injection. The maturational status of the oocytes was recorded according to published criteria (Veeck, 1986) .
Blood samples were obtained from each subject on the day of oocyte retrieval for comparative purposes with follicular uid. Also, we assessed the relationship of both circulating and follicular¯uid concentrations of VEGF and adrenomedullin and parameters of ovarian response (age, basal FSH levels, peak estradiol serum concentration, oocytes retrieved and oocyte maturiry), to stimulation with gonadotrophins as well as the IVF outcome (fertilization rate and clinical pregnancy).
Specimen collection and cell cultures
Human follicular¯uid macrophages were obtained from pooled follicular¯uid of individual patients (n = 20) following a method previously described to isolate peritoneal macrophages from ascites of cirrhotic patients (Pe Ârez-Ruiz et al., 1999) . In brief, pooled clear follicular¯uid (~35 ml obtained from~13±17 different follicles) from each individual patient was centrifuged at 200 g for 10 min at 4°C and the resulting supernatant was stored at ±20°C until further measurements. Then, 2 Q 10 4 cells/well (n = 10) or 10 5 cells/well (n = 10) were seeded on 96-well plates (BD Falcon, Bedford, MA) in their own follicular¯uid. After incubation for 90 min at 37°C in a humidi®ed atmosphere (95% air and 5% CO 2 ), the nonadherent cells were removed from the wells by three washes with 300 ml of pre-warmed Dulbecco's phosphate-buffered saline (DPBS), and the remaining adherent cells were incubated with 300 ml of phenol red-free RPMI 1640 medium supplemented with 2% heat-inactivated fetal calf serum (FCS), penicillin/streptomycin (50 U/ml and 50 mg/ml) and Lglutamine (2 mmol/l) at 37°C in a humidi®ed atmosphere (95% air and 5% CO 2 ). About 98 T 2% of the adherent cells were non-speci®c esterase-positive which is the most commonly used marker for monocytes (Auger and Ross, 1992) , and had the morphological appearance of macrophages (large cells, spread on the plate with a marked ruf®ng of the membrane border) when examined after Giemsa staining. In addition, preliminary experiments showed positive immunoreactivity for CD68 in the isolated cells. Accumulation of VEGF and adrenomedullin in the culture medium of the isolated human follicular¯uid macrophages seeded on 96-well plates was determined at variable time intervals ranging between 0 and 48 h.
Human granulosa cells were isolated from follicular¯uid obtained during oocyte retrieval. After removing the oocytes, the remaining cumulus cells from each individual patient (n = 20) were collected under the microscope from¯uids without obvious blood contamination, pooled and washed twice with Ham's-HEPES F-10 medium supplemented with 2% FCS, penicillin/streptomycin (50 U/ml and 50 mg/ml) and L-glutamine (2 mmol/l). Then, cells were transferred to a 12 ml tube containing 2 ml of supplemented Ham's-HEPES F-10 medium and cell clusters were mechanically separated by vigorous pipetting. After centrifugation at 160 g (10 min, room temperature), the resulting pellet was gently resuspended in 0.5 ml of supplemented Ham's-HEPES F-10 medium. Cell number and viability were assessed by the trypan blue exclusion test using a haemocytometer. Morphological examination of isolated samples revealed typical granulosa cell morphology and the purity of the cell culture was assessed by positive a-inhibin but negative CD68 immunohistochemical staining, with <1% being CD68 positive cells. Then 2 Q 10 4 cells/well (n = 10) or 10 5 cells/well (n = 10) were seeded in 96-well plates and incubated for 24 h at 37°C under humidi®ed conditions (95% air, 5% CO 2 ). Thereafter, cells were washed with 300 ml of pre-warmed DPBS to remove cells in suspension; attached cells were cultured in 300 ml of supplemented Ham's-HEPES F-10 medium at 37°C in a humidi®ed environment (95% air, 5% CO 2 ). Accumulation of VEGF and adrenomedullin in the culture medium of the isolated human granulosa cells seeded on 96-well plates was determined at variable time intervals ranging between 0 and 48 h.
Peripheral monocytes were chosen to assess whether other cells of the monocyte/macrophage linage exhibit a secretion pattern of VEGF and adrenomedullin similar to that of macrophages isolated from the follicular¯uid. Peripheral monocytes can be obtained easily by venipuncture, thus avoiding unnecessary interventions in the subject. Cells were isolated as previously reported (Pe Ârez-Ruiz et al., 1999) from fresh blood by venipuncture using acid citrate dextrose as anticoagulant. Blood was centrifuged at 80 g (15 min, room temperature), and leukocytes were fractionated by Ficoll± Hypaque gradient centrifugation. Then monocytes were obtained from the mononuclear cell layer according to the method of Denholm and Wolber (1991) . Brie¯y, mononuclear cells were resuspended in DPBS plus 0.1% bovine serum albumin, added to a Percoll:10Q Hanks' balanced salt solution (HBSS) mixture (10:1.65) in a 10 Q 1.5 cm round-bottom polypropylene tube and centrifuged at 160 g, 25°C for 30 min. Monocytes were collected from the upper 5 mm of the gradient, counted in a haemocytometer and viability was estimated by trypan blue staining. Cytospin preparations of monocytes stained with Giemsa con®rmed a 90±94% pure monocyte population. Then, 10 5 viable cells/well (n = 5) were seeded on 96-well plates and incubated overnight with supplemented phenol red-free RPMI 1640 medium under standard conditions of humidity and temperature (37°C, 95% air, 5% CO 2 ). Finally, cells were washed with 300 ml of prewarmed DPBS and the remaining adherent cells were cultured for 48 h in 300 ml phenol red-free RPMI 1640 medium supplemented with 2% heat-inactivated FCS, penicillin/ streptomycin (50 U/ml and 50 mg/ml) and L-glutamine (2 mmol/l) at 37°C in a humidi®ed atmosphere (95% air, 5% CO 2 ). Culture samples obtained at different intervals between 0 and 48 h were stored at ±20°C for analysis of VEGF and adrenomedulllin concentrations.
Laboratory methods
The laboratory methods for VEGF and adrenomedullin measurement used have been reported previously (Manau et al., 2000) . Culture supernatants, follicular¯uid and plasma VEGF concentrations were quanti®ed by enzyme-linked immunosorbent assay (ELISA; Quantikine Human VEGF Immunoassay, R&D Systems Inc., Minneapolis, MN) that recognizes the soluble isoforms VEGF 121 and VEGF 165 which are the most frequently expressed spliced variants of the VEGF A gene. Intra-and inter-assay coef®cients of variation (CVs) in plasma samples were 7.1 and 9.2%, respectively. In follicular¯uid, these values were 4.7 and 7.5%, respectively. The portion of inhibition produced by serial dilution of follicular¯uid samples (n = 5) paralleled the standard curve (data not shown). The recovery of 400 pg of recombinant human VEGF 165 added to follicular samples was 108%, and the recovery of 100 pg was 106%.
The adrenomedullin concentrations of plasma, follicular uid and culture supernatants were measured by radioimmunoassay (Phoenix Pharmaceuticals, Mountain View, CA) after extraction of adrenomedullin on Sep-Pack C18 cartridges (Waters Associates, Mildford, MA). Brie¯y,¯uid samples (2 ml) were acidi®ed with 4% acetic acid (3 ml) and applied twice to cartridges pre-activated with methanol, distilled water and 4% acetic acid. Cartridges were then washed with distilled water and 25% ethanol, and adrenomedullin was eluted with 4 ml of glacial acetic acid in 86% ethanol. The eluted adrenomedullin was then dried and reconstituted for radioimmunoassay. The recovery rate for the extraction procedure was 67, 78 and 85%, as determined by the addition of 125 I-labelled adrenomedullin to plasma, follicular¯uid or culture supernatant, respectively. Maximum binding of the anti-adrenomedullin antibody in the radioimmunoassay was 40.6%. The sensitivity of the assay was 5 pg/ tube and intra-and inter-assay CVs were 12.4 and 13.6%, respectively. These values were similar to those reported in other investigations (Cuzzola et al., 2001; Honshi et al., 2003) . Dilution curves obtained from plasma, follicular extracts or culture supernantants paralleled the standard curve.
Statistical analysis
Data were analysed using SPSS statistical software using the non-parametric Mann±Whitney U-test. Results are expressed as median and range and were considered signi®cant at a Pvalue <0.05. Table I , follicular¯uid concentrations of both VEGF and adrenomedullin were signi®cantly higher than those found in plasma (P < 0.0001). However, neither serum levels on the day of oocyte aspiration nor follicular¯uid concentrations of VEGF or adrenomedullin were correlated with parameters of ovarian response to gonadotrophin stimulation or IVF outcome (data not shown).
Results
As shown in
Adrenomedullin and VEGF production by follicular¯uid macrophages and luteinized granulosa cells is also summarized in Table I . After 48 h, accumulation of VEGF in the culture medium of follicular¯uid macrophages was signi®cantly higher than that released in the culture medium of luteinized granulosa cells. In contrast, the production rate of adrenomedullin by follicular¯uid macrophages was similar to that found in granulosa cells.
Preliminary experiments performed in our laboratory demonstrated that concentrations lower than 10 5 cells per well do not allow enough sensitivity to measure the adrenomedullin released by the cells accurately. For this reason, we were unable to perform time course production experiments of adrenomedullin either in follicular¯uid macrophages or in luteinized granulosa cells since the total amount of cells obtained from each patient precluded this type of experiment. However, this was not the case regarding VEGF where concentrations of 2 Q 10 4 cells per well resulted in suf®cient amounts of VEGF to be measured.
The time course of production of VEGF in follicular¯uid macrophages from ®ve patients is shown in Figure 1 . VEGF secreted by follicular¯uid macrophages increased progressively within 48 h of cell culture. A similar response pattern was observed with the culture medium of luteinized granulosa cells (Figure 2) . However, the production rate of this substance was higher in cultured macrophages compared with cultured granulosa cells.
To examine whether VEGF and adrenomedullin production in follicular¯uid macrophages is a speci®c characteristic of these cells or also occurs in other cells of the monocyte/ Values are expressed as median and range. Values in columns with common superscripts were signi®cantly different: a,b P < 0.0001; c P < 0.005. Figure 1 . Time course of production of VEGF by follicular¯uid macrophages. Cells were isolated as described, seeded at a concentration of 2 Q 10 4 cells/well, and the VEGF concentration in the culture medium was measured by ELISA (®ve separate cultures). The box contains the values between the 25th and 75th percentiles and the horizontal line is the median; whiskers show the range of the data. macrophage cell lineage, the in vitro production of VEGF and adrenomedullin was also assessed in peripheral blood monocytes obtained from patients on the day of oocyte retrieval. Peripheral blood monocytes did not produce either VEGF or adrenomedullin after 48 h of cell culture (data not shown).
Discussion
In the past, the understanding of ovarian function has emphasized the endocrine control exerted by the pituitarysynthesized gonadotrophins over follicle development, ovulation, corpora lutea development and steroidogenesis. However, recent advances of ovarian physiology have shown that ovarian function is regulated by numerous locally produced bioactive substances acting through paracrine or autocrine pathways among the different categories of constituent ovarian cells (Ben-Rafael and Orvieto, 1992; Cohen and Pollard, 1996; Mori et al., 1996; Bukulmez and Arici, 2000) . In addition to gonadal steroids and prostaglandins which represent the earliest line of intraovarian regulators in classic ovarian endocrinology, several known and unknown growth factors have come to the fore as the second line of local regulators. On the other hand, with the advent of molecular immunology, a variety of cytokines have been proposed as the third line of the regulatory machinery complex for their pleiotropic actions not only on immune cells but also on somatic cells. Thus, according to present data, these three lines of intraovarian regulators appear to work alone or in combination at different phases over the range of folliculogeneic, ovulatory and corpus luteum function (Mori et al., 1996) . In fact, it is now well established that an immuno-endocrine interaction exists in reproduction (BenRafael and Orvieto, 1992; Bukulmez and Arici, 2000) . The present study adds new evidence favouring the concept that, in the ovary, the immune system contributes to the regulation of gonadal function (Mori et al., 1996; Bukulmez and Arici, 2000) by showing that both follicular¯uid macrophages and luteinized granulosa cells are ovarian sources of VEGF and adrenomedullin. The following facts support this contention. First, there was a signi®cantly higher amount of both VEGF and adrenomedullin present in follicular¯uid relative to plasma. Secondly, it is accepted that the ovary is not an immunologically privileged site and there is a traf®c of leukocytes in and out of ovarian tissues concomitant with marked morphological and functional changes during the ovarian cycle. Thus, monocytes of the blood may differentiate into macrophages as they enter ovarian tissues (Bra Ènnstro Èm and Norman, 1993) . However, VEGF and adrenomedullin production is a characteristic of follicular¯uid macrophages as we showed that circulating monocytes obtained from the same patient on the day of follicular puncture did not produce these substances.
The role of VEGF in ovarian physiology and pathology has been reviewed recently (Geva and Jaffe, 2000) . In the corpus luteum, luteinized granulosa and thecal cells exhibited staining for VEGF. However, with further maturation, lutein cell staining for VEGF protein became more variable. The theca lutein cell staining was less intense than exhibited by most granulosa lutein cells (Geva and Jaffe, 2000) . This notwithstanding, a signi®cant proportion of the non-luteal cells present in the corpus luteum are constituents of the immune system, such as lymphocytes and macrophages (Bra Ènnstro Èm and Norman, 1993) . In the human corpus luteum, the macrophage is the predominant leukocyte, comprising at least 10% of the total cells (Bra Ènnstro Èm and Fride Ân, 1997). As well as being primarily phagocytic in nature, immune cells are now believed to be directly involved in regulating luteal function through the integration of immunological and endocrinological mechanisms throughout the life-span of the corpus luteum (Bra Ènnstro Èm and Fride Ân, 1997). Macrophages are terminally differentiated cells demonstrating wide heterogeneity in biological function. They produce a number of potent angiogenic cytokines and growth factors and modulate events in the extracellular matrixdegrading enzymes and modulating enzymes which may be important in angiogenesis and tissue reorganization (Bra Ènnstro Èm and Fride Ân, 1997; Ono et al., 1999) . This study adds further evidence in this regard by showing for the ®rst time that follicular¯uid macrophages produce signi®cant amounts of VEGF, at an even higher rate than that of luteinized granulosa cells. The potential implications of these ®ndings for corpus luteum formation warrant further investigation.
Adrenomedullin elicits a number of physiological actions, including a regulatory function on the release or activity of several hormones (Hinson et al., 2000) . During the normal menstrual cycle, it has been shown that plasmatic adrenomedullin levels¯uctuate with the cyclic changes in gonadotrophins and ovarian steroids (Marinoni et al., 2000) . Moreover, adrenomedullin and its receptor have been found in human granulosa cells at the pre-ovulatory stage and at the midluteal phase, demonstrating that adrenomedullin acts as a local factor to enhance progesterone production by these cells (Moriyama et al., 2000) . The identi®cation of adrenomedullin and its receptors in human granulosa cells suggests that at least part of them may be produced by the ovary itself. Consistently, immunohistochemical staining for adrenomedullin showed that it was most abundant in granulosa lutein cells at the midluteal phase, less abundant in granulosa cells in dominant follicles, and least abundant in granulosa cells in primordial and preantral follicles in the human ovary (Moriyama et al., 2000) . This is inconsistent with the previous study by Abe et al. (1998) who found that the maturation and luteinization of rat granulosa cells induced by gonadotrophins were associated with a signi®cant suppression in adrenomedullin mRNA expression in those cells cultured in vitro. The reason for the difference in the adrenomedullin expression in the human and rat ovary is not known. However, the apparent difference between the data obtained with rat granulosa cells in vitro and human granulosa cells in vivo may be due to species differences or to differences in the environment in which granulosa cell specimens were luteinized, i.e. in vivo or in vitro (Moriyama et al., 2000) . The present study adds new information on the subject by showing that both granulosa lutein cells and follicular¯uid macrophages have a contributory role in adrenomedullin production by the ovary.
We (Manau et al., 2000) and others (Friedman et al., 1998) previously have reported that follicular¯uid concentrations of VEGF and adrenomedullin can be useful markers of the ovarian response in patients undergoing IVF. This could not be con®rmed in the present study because only relatively young patients with normal basal FSH and adequate ovarian response to gonadotrophin stimulation were included in this investigation. In fact, discrete age populations were chosen arbitrarily in those previous studies in an effort to exaggerate potential physiological differences among groups of women based on age.
In conclusion, this study suggested for the ®rst time that both luteinized granulosa cells and macrophages are actively secreting VEGF and adrenomedullin into follicular¯uid in the human ovary.
